US Edition
OP-ED: Why UK Health Insurers Were Right to Reject New Alzheimer’s Drugs
Summary by Being Patient
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
OP-ED: Why UK Health Insurers Were Right to Reject New Alzheimer’s Drugs
When is it right to reject an expensive new drug? University of Liverpool researchers Paul Atkinson and Sally Sheard respond to the UK’s recent... The post OP-ED: Why UK Health Insurers Were Right to Reject New Alzheimer’s Drugs appeared first on Being Patient.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
